MedTrace Logo

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

NCT06389617 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-29

No results posted yet for this study

Summary

To compare the analgesic properties of ultrasound guided supraclavicular block using ropivacaine 0.5% in arteriovenous fistula creation when used in combination with intravenous administered dexamethasone at 4mg and 8 mg as an adjuvant

Conditions

  • End Stage Renal Failure

Interventions

DRUG

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

Sponsors & Collaborators

  • Hospital Universiti Sains Malaysia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-11-30
Completion
2024-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06389617 on ClinicalTrials.gov